ReviewMolecular and cellular biochemistry2006
ALR and liver regeneration.
Review in Molecular and cellular biochemistry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 45 citations in OpenAlex.
- Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma.Cancers · 2022Review
- Distribution of SiOInternational journal of nanomedicine · 2019Article
- The mitochondrial oxidoreductase CHCHD4 is present in a semi-oxidized state in vivo.Redox biology · 2018Article
- Site-specific insertion of selenium into the redox-active disulfide of the flavoprotein augmenter of liver regeneration.Archives of biochemistry and biophysics · 2014Article
- Establishment and primary clinical application of competitive inhibition for measurement of augmenter of liver regeneration.Experimental and therapeutic medicine · 2014Article
- Genetic models of apoptosis-induced proliferation decipher activation of JNK and identify a requirement of EGFR signaling for tissue regenerative responses in Drosophila.PLoS genetics · 2014Article
- Newly established human liver cell line: a potential cell source for the bioartificial liver in the future.Human cell · 2013Article
- Human augmenter of liver regeneration: probing the catalytic mechanism of a flavin-dependent sulfhydryl oxidase.Biochemistry · 2013Article
- Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration.Molecular medicine (Cambridge, Mass.) · 2013Article
- Adenoviral gene transfer of hepatic stimulator substance confers resistance against hepatic ischemia-reperfusion injury by improving mitochondrial function.Human gene therapy · 2013Article
- Hepatic stimulator substance alleviates toxin-induced and immune-mediated liver injury and fibrosis in rats.Digestive diseases and sciences · 2012Article
- Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance.Journal of molecular medicine (Berlin, Germany) · 2011Article
- Structure of a baculovirus sulfhydryl oxidase, a highly divergent member of the erv flavoenzyme family.Journal of virology · 2011Article
- Transplantation of porcine hepatocytes cultured with polylactic Acid-o-carboxymethylated chitosan nanoparticles promotes liver regeneration in acute liver failure rats.Journal of drug delivery · 2011Article
- Structure of the human sulfhydryl oxidase augmenter of liver regeneration and characterization of a human mutation causing an autosomal recessive myopathy .Biochemistry · 2010Article
- Augmenter of liver regeneration: substrate specificity of a flavin-dependent oxidoreductase from the mitochondrial intermembrane space.Biochemistry · 2009Article
- Genetic recombinant expression and characterization of human augmenter of liver regeneration.Digestive diseases and sciences · 2009Article
- Three genes control the timing, the site and the size of blastema formation in Drosophila.Developmental biology · 2008Article
- Catch me if you can! Oxidative protein trapping in the intermembrane space of mitochondria.The Journal of cell biology · 2007Review
- FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.Proceedings of the National Academy of Sciences of the United States of America · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver possesses the capacity to restore its tissue mass and attain optimal volume in response to physical, infectious and toxic injury. The extraordinary ability of liver to regenerate is the effect of cross-talk between growth factors, cytokines, matrix components and many other factors. In this review we present recent findings and existing information about mechanisms that regulate liver growth, paying attention to augmenter of liver regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.